 |
|
Efficacy of triple diuretic treatment in continuous ambulatory peritoneal dialysis patients: A randomized controlled trial
Raweewan Witoon, Somchai Yongsiri, Prapan Buranaburidej, Pacharin Nanna
Kidney Res Clin Pract. 2019;38(1):108-115. Published online 2019 Mar 31 DOI: https://doi.org/10.23876/j.krcp.18.0115
|
|
Citations to this article as recorded by
 Peritoneal Dialysis Care for People with Diabetes, Polycystic Kidney Disease, or Advanced Liver Disease
Shailesh Agarwal, Laura Gillis, Martin Wilkie
Clinical Journal of the American Society of Nephrology.2024;[Epub] CrossRef Aldosterone antagonists for people with chronic kidney disease requiring dialysis
Takeshi Hasegawa, Hiroki Nishiwaki, Erika Ota, William MM Levack, Hisashi Noma
Cochrane Database of Systematic Reviews.2021;[Epub] CrossRef Volume management as a key dimension of a high-quality PD prescription
Angela Yee-Moon Wang, Jie Dong, Xiao Xu, Simon Davies
Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis.2020; 40(3): 282. CrossRef Impact of high-dose diuretic combination therapy on volume status in peritoneal dialysis patients
Yong-Lim Kim
Kidney Research and Clinical Practice.2019; 38(1): 3. CrossRef Renin Angiotensin Aldosterone System Blockades Does Not Protect Residual Renal Function in Patients with Hemodialysis at 1 Year After Dialysis Initiation: A Prospective Observational Cohort Study
Kyung Don Yoo, Clara Tammy Kim, Soie Kwon, Jeonghwan Lee, Yun Kyu Oh, Shin-Wook Kang, Chul Woo Yang, Yong-Lim Kim, Yon Su Kim, Chun Soo Lim, Jung Pyo Lee
Scientific Reports.2019;[Epub] CrossRef
|